Hansoh Pharmaceutical Group

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• 翰森製藥(3692)歐盟撤銷阿美樂替尼上市許可 強調屬程序問題並計劃盡快重新申請 (öffnet in neuem Tab)

  Minichart · 27.09.2026

• Hansoh Pharmaceutical Group Co Ltd's Dividend Analysis (öffnet in neuem Tab)

  GuruFocus.com · 22.09.2026

• Sector Update: Healthcare Stocks Gain Late Afternoon (öffnet in neuem Tab)

  MT Newswires · 28.07.2026

• 
  Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill (öffnet in neuem Tab)

  BioPharma Dive · 14.07.2026

• GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm (öffnet in neuem Tab)

  11.05.2026

• 
  GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer (öffnet in neuem Tab)

  Zacks · 23.03.2026

• 
  Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients (öffnet in neuem Tab)

  GlobeNewswire · 09.03.2026

• 
  Terns Pharmaceuticals (TERN) Valuation Check After Expanded Global Rights To TERN-701 (öffnet in neuem Tab)

  Simply Wall St. · 03.02.2026

• 
  Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment (öffnet in neuem Tab)

  Insider Monkey · 02.02.2026